May 8, 2025
In the treatment of non-Hodgkin lymphoma with CD19 chimeric antigen receptor (CAR) T-cell therapy, baseline kidney function did not appear to be associated with an increased […]
May 8, 2025
Despite the rising incidence rates of breast cancer among younger women, advances in treatment and detection appear to reduce breast cancer mortality in this population. New […]
May 7, 2025
TOPLINE: Sarcopenia, a hallmark of cancer cachexia, is associated with poor outcomes in chimeric antigen receptor (CAR) T-cell therapy, which can exacerbate muscle loss through inflammatory […]
May 7, 2025
TOPLINE: After a median follow-up of 99 months, salvage high-dose chemotherapy and autologous stem cell transplantation (sHDCT/ASCT) showed no survival benefit compared with continuous lenalidomide/dexamethasone in […]
May 7, 2025
TOPLINE: A study of 162,500 patients with uterine cancer found that survival rates varied significantly by race and geographic location, with Black patients experiencing the worst […]
May 6, 2025
Adding pembrolizumab to standard-of-care treatment improved event-free survival (EFS) in locally advanced head and neck squamous cell carcinoma (HNSCC), according to new results of the KEYNOTE-689 […]
May 6, 2025
TOPLINE: Among women aged 70 years or older with screen-detected breast cancer, those with a history of screening mammography within 5 years of their diagnosis were […]
May 5, 2025
TOPLINE: In a real-world analysis, the relative risk of myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML) was higher in patients who received chemotherapy plus poly(ADP-ribose) […]
May 5, 2025
A trial testing the combination of the anti-TIGIT antibody tiragolumab and atezolizumab vs atezolizumab in previously untreated programmed cell death ligand 1 (PD-L1)–high locally advanced unresectable […]